Resources
About Us
Home Report
Store
Microbubbles/Ultrasound Contrast Agents Market
Microbubbles/Ultrasound Contrast Agents Market by Application (Diagnostic Imaging [Cardiovascular, Renal, Abdominal, Breast] Therapeutics) Type (Lipid, Protein, Polymer) End User (Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2030
Report ID:MRHC - 10451 Pages: 190 Jun-2023 Formats*: PDF Category: Healthcare Delivery: 24 to 48 HoursThe Microbubbles/Ultrasound Contrast Agents Market is projected to reach $1.95 billion by 2030, at a CAGR of 15.2% from 2023 to 2030.
Microbubbles are gas-filled microspheres of lipid, protein, and polymer shells. They are used as blood-pool agents in radiology and cardiology and have targeted agents for molecular imaging. Microbubbles can act as therapeutic agents and echo-enhancers.
The growing aging population, coupled with the rising prevalence of chronic diseases, technological advancements in ultrasound imaging, high demand for image & diagnostics-guided procedures, and favorable reimbursement policies for contrast-enhanced ultrasonography, are driving the growth of this market. However, the complexity involved in contrast-enhanced ultrasound (CEUS) is expected to restrain the market. In addition, increasing microbubbles/ultrasound contrast agents-related research activities will offer growth opportunities for the market growth. However, the lack of skilled professionals is a major challenge for market growth.
Technological Advances in Ultrasound Imaging to Drive the Demand for Microbubbles/Ultrasound Contrast Agents
Ultrasound imaging has tremendously advanced significantly in recent years, leading to improved image quality, the development of new technologies, and increased automation. These advancements have improved patients’ experiences and made diagnostics more precise.
Recent advances in ultrasound imaging include image quality improvements, in which ultrasound is now used in interventional procedures dominated by computed tomography (CT) and magnetic resonance imaging (MRI). Further, volumetric ultrasound technology has been under development for several years. It can be used to detect tumors, analyze cardiac function as well as create images with more depth than traditional sonograms. These ultrasounds can make diagnosis easier and more effective in some instances.
Further, newer technologies are set to transform the ultrasound practice. Sonoelastography has been in development for the past two decades. It utilizes the same machine which does b-mode ultrasound to measure tissue stiffness. Another development is the utilization of ultrasound contrast agents. CEUS has been available in China, Europe, Australia, and Canada for many years however has not been available in the U.S. outside of echocardiography. This contrast-enhanced ultrasound allows more sensitivity for tumor detection, enabling ultrasound to expand multiple functions performed by MRI and CT.
Additionally, healthcare reform plays an important role in the broad-level adoption of ultrasound technology; With the current use of CT and MRI, healthcare reform favors the more widespread adoption of ultrasound, as it costs less than MRI and CT.
Thus, these technological advancements in ultrasound imaging have led to enhanced diagnostics capabilities and better patient outcomes.
Click here to: Get a Free Sample Copy of this report
Favorable Reimbursement Policies for Contrast-Enhanced Procedures to Drive the Demand for Microbubbles/Ultrasound Contrast Agents
In recent years, the usage of ultrasound contrast imaging for clinical applications has increased. Ultrasound contrast imaging is preferable for healthcare professionals due to real-time capability, low cost, and convenience. Further, ultrasound imaging offers good quantitative data, temporal resolution, portability, less ionizing radiation, and non-invasiveness compared to other imaging modalities.
Furthermore, in the U.S., Medicare reimburses film and digital contrast-enhanced mammography procedures. Also, The Centers for Medicare and Services (CMS) established the National Correct Coding Initiative (NCCI) program to promote the correct coding of services. Further, The National Correct Coding Initiative (NCCI) Policy Manual gives certain coding policies for Medicare, including those related to contrast-enhanced procedures.
Thus, reimbursement policies for contrast-enhanced procedures vary depending on the procedure and insurance provider. It is very important to consult the relevant guidelines as well as policies to ensure proper coding and billing.
Key Findings in the Microbubbles/Ultrasound Contrast Agents Market Study:
In 2023, The Lipid Microbubbles Segment to Account for the Largest Share of the Microbubbles/Ultrasound Contrast Agents Market
Based on type, the microbubbles/ultrasound contrast agents market is segmented into lipid microbubbles, protein microbubbles, and polymer microbubbles. In 2023, the lipid microbubbles segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The lipid-based microbubbles are formulations used for drug delivery and biomedical imaging. Factors such as pressure resistance, more stability and flexibility, and less damage to the human body support the large market share of the segment. Furthermore, there are several commercial lipid-based microbubbles formulations approved for clinical use in the U.S., such as DEFINITY, an ultrasound contrast imaging agent (Lantheus Holdings, Inc.), and SonoVue, a second-generation ultrasound contrast agent (Bracco S.p.A.). Thus, the high preference for lipid-based microbubbles and the presence of several lipid-based microbubbles in the market support the largest share of the market.
In 2023, The Diagnostic Imaging Segment to Account for the Largest Share of the Microbubbles/Ultrasound Contrast Agents Market
Based on the application, the microbubbles/ultrasound contrast agents market is segmented into diagnostic imaging and therapeutic applications. The diagnostics imaging segment is further divided into cardiovascular imaging, renal imaging, abdominal imaging, and breast imaging. In 2023, the diagnostic imaging segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The large market share of this segment is attributed to the increase in awareness regarding the early diagnosis of diseases, technological advancements in diagnostic imaging, and the wide scope of the use of ultrasound devices for diagnostic applications.
In 2023, The Hospitals/Clinics Segment to Account for the Largest Share of the Microbubbles/Ultrasound Contrast Agents Market
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. Hospitals & clinics are preliminary healthcare facilities. The large market share of this segment is attributed to increased hospitalizations due to various diseases and the high disease burden in the geriatric population requiring ultrasound for diagnostic and therapeutic purposes.
North America to Dominate the Market in 2023
In 2023, North America is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The key factors contributing to this large market share are the high burden of the geriatric population, availability & accessibility of well-equipped systems, advanced healthcare infrastructure, increasing technological developments in hospitals, as well as the presence of skilled professionals at hospitals; thus, patients can access better treatment.
Key Players
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market participants in the past few years. The key players profiled in the microbubbles/ultrasound contrast agents market report are Lantheus Holdings, Inc. (U.S.), GE HealthCare Technologies Inc. (U.S.), Bracco S.p.A. (Italy), Bristol-Myers Squibb Company (U.S.), Daiichi Sankyo Company, Limited (Japan), nanoPET Pharma GmbH (Germany), Leriva (Greece), Siemens Healthineers AG (Germany), Bayer AG (Germany), and Fujifilm Holdings Corporation (Japan).
Scope of the Report:
Microbubbles/Ultrasound Contrast Agents Market Assessment, by Type
- Lipid Microbubbles
- Protein Microbubbles
- Polymer Microbubbles
Microbubbles/Ultrasound Contrast Agents Market Assessment, by Application
- Diagnostics Imaging
- Cardiovascular Imaging
- Renal Imaging
- Abdominal Imaging
- Breast Imaging
- Other Diagnostics Imaging Applications
- Therapeutics Applications
(Note: Other diagnostics imaging applications include cancer and ocular)
Microbubbles/Ultrasound Contrast Agents Market Assessment, by End User
- Hospitals & Clinics
- Diagnostics Laboratories
- Other End Users
(Note: Other end users include pharmaceutical & biotech companies and research & academic institutes)
Microbubbles/Ultrasound Contrast Agents Market Assessment, by Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Key questions answered in the report:
This study covers the market size and forecasts for various microbubbles/ultrasound contrast agents offered by key companies, and it can be delivered to hospitals & clinics and diagnostics laboratories.
The microbubbles/ultrasound contrast agents market is projected to reach $1.95 billion by 2030, at a CAGR of 15.2% during the forecast period.
In 2023, the lipid microbubbles segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. Enhanced ultrasound imaging, easy formulation of lipid mixtures, including targeting ligand-lipid conjugates, and a good safety and risk-benefit profile are some of the factors contributing to this segment's large market share.
In 2023, the diagnostics imaging segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The large market share of this segment is attributed to the increase in awareness of the early diagnosis of diseases, technological developments in diagnostic imaging, and the wide scope of the use of ultrasound devices for diagnostic applications.
In 2023, the hospitals & clinics segment is expected to account for the largest share of the microbubbles/ultrasound contrast agents market. The rise in the number of patient visits to hospitals, well-established infrastructure to get effective treatment, increasing technological advancements in hospitals & clinics, and the increasing number of healthcare facilities in emerging countries support the growth of this market.
Based on geography, which region is expected to account for the largest share of the market in 2023?
Based on geography, North America is expected to account for the largest share of the market in 2023. The large share of this market is attributed to the high burden of the geriatric population and chronic disease prevalence, increasing investment in the healthcare sector, and the growing number of healthcare settings.
A growing aging population coupled with the rising prevalence of chronic diseases, technological advancements in ultrasound imaging, high demand for image & diagnostics-guided procedures, and favorable reimbursement policies for contrast-enhanced ultrasonography are driving the growth of this market. In addition, increasing microbubbles/ultrasound contrast agents-related research will likely offer growth opportunities for the market growth.
The key players profiled in the microbubbles/ultrasound contrast agents market report are Lantheus Holdings, Inc. (U.S.), GE HealthCare Technologies Inc. (U.S.), Bracco S.p.A. (Italy), Bristol-Myers Squibb Company (U.S.), Daiichi Sankyo Company, Limited (Japan), nanoPET Pharma GmbH (Germany), Leriva (Greece), Siemens Healthineers AG (Germany), Bayer AG (Germany), and Fujifilm Holdings Corporation (Japan).
1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Aging Population Coupled with the Increasing Prevalence of Chronic Diseases
4.2.2. Technological Advancements in Ultrasound Imaging
4.2.3. High Demand for Image & Diagnostics-guided Procedures
4.2.4. Favorable Reimbursement Policies for Contrast-enhanced Procedures
4.3. Restraints
4.3.1. Complexity involved in Contrast-enhanced Ultrasound (CEUS) Procedures
4.4. Opportunities
4.4.1. Increasing Microbubbles/Ultrasound Contrast Agents-related Research Activities
4.5. Challenges
4.5.1. Lack of Skilled Professionals
4.6. Trend: Expansion- A Key Growth Strategy Adopted By Market Players
4.7. Regulatory Scenario
4.8. Pricing Analysis
4.9. Porter’s 5 Force Analysis
5. Microbubbles/Ultrasound Contrast Agents Market Assessment—by Type
5.1. Overview
5.2. Lipid Microbubbles
5.3. Protein Microbubbles
5.4. Polymer Microbubbles
6. Microbubbles/Ultrasound Contrast Agents Market Assessment—by Application
6.1. Overview
6.2. Diagnostic Imaging
6.2.1. Cardiovascular Imaging
6.2.2 Renal Imaging
6.2.3. Abdominal Imaging
6.2.4. Breast Imaging
6.2.5. Other Diagnostic Imaging Applications
6.3. Therapeutic Applications
7. Microbubbles/Ultrasound Contrast Agents Market Assessment—by End User
7.1. Overview
7.2. Hospitals & Clinics
7.3. Diagnostics Laboratories
7.4. Other End Users
8. Microbubbles/Ultrasound Contrast Agents Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. U.K.
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Dashboard
9.3.1. Industry Leaders
9.3.2. Vanguards
9.3.3. Market Differentiators
9.3.4. Emerging Companies
9.4. Vendor Market Positioning
9.5. Market Players Ranking, 2022
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)
10.1. Lantheus Holdings, Inc.
10.2. GE HealthCare Technologies Inc.
10.3. Bracco S.p.A.
10.4. Bristol-Myers Squibb Company
10.5. Daiichi Sankyo Company, Limited
10.6. nanoPET Pharma GmbH
10.7. Leriva
10.8. Siemens Healthineers AG
10.9. Bayer AG
10.10. Fujifilm Holdings Corporation
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 2 Global Lipid Microbubbles Market, by Country/Region, 2021–2030 (USD Million)
Table 3 Global Protein Microbubbles Market, by Country/Region, 2021–2030 (USD Million)
Table 4 Global Polymer Microbubbles Market, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 6 Global Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 7 Global Diagnostics Imaging Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Cardiovascular Imaging Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Renal Imaging Market, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Abdominal Imaging Market, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Breast Imaging Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Other Diagnostics Imaging Applications Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Therapeutic Applications Market, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 15 Global Microbubbles/Ultrasound Contrast Agents Market for Hospitals & Clinics, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Microbubbles/Ultrasound Contrast Agents Market for Diagnostics Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Microbubbles/Ultrasound Contrast Agents Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 18 North America: Microbubbles/Ultrasound Contrast Agents Market, by Country, 2021–2030 (USD Million)
Table 19 North America: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 20 North America: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 21 North America: Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type,2021–2030(USD Million)
Table 22 North America: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 23 U.S.: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 24 U.S.: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 25 U.S.: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 26 U.S.: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 27 Canada: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 28 Canada: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 29 Canada: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 30 Canada: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 31 Europe: Microbubbles/Ultrasound Contrast Agents Market, by Country /Region, 2021–2030 (USD Million)
Table 32 Europe: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 33 Europe: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 34 Europe: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 35 Europe: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 36 U.K.: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 37 U.K.: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 38 U.K.: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 39 U.K.: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 40 Germany: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 41 Germany: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 42 Germany: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 43 Germany: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 44 France: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 45 France: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 46 France: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 47 France: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 48 Italy: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 49 Italy: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 50 Italy: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 51 Italy: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 52 Spain: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 53 Spain: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 54 Spain: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 55 Spain: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 56 Rest of Europe: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 57 Rest of Europe: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 58 Rest of Europe: Microbubbles Contrast Agents Market for Diagnostic Imaging Applications,by Type,2021–2030(USD Million)
Table 59 Rest of Europe: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 60 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by Country /Region, 2021–2030 (USD Million)
Table 61 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 62 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 63 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications,by Type,2021–2030(USD Million)
Table 64 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 65 China: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 66 China: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 67 China: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 68 China: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 69 Japan: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 70 Japan: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 71 Japan: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 72 Japan: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 73 India: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 74 India: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 75 India: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 76 India: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million
Table 77 Rest of Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 78 Rest of Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 79 Rest of Asia-Pacific: Microbubbles Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 80 Rest of Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 81 Latin America: Microbubbles/Ultrasound Contrast Agents Market, by Country /Region, 2021–2030 (USD Million)
Table 82 Latin America: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 83 Latin America: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 84 Latin America: Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 85 Latin America: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 86 Brazil: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 87 Brazil: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 88 Brazil: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 89 Brazil: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 90 Mexico: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 91 Mexico: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 92 Mexico: Microbubbles/Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 93 Mexico: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 94 Rest of Latin America: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 95 Rest of Latin America: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 96 Rest of Latin America: Ultrasound Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 97 Rest of Latin America: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
Table 98 Middle East & Africa: Microbubbles/Ultrasound Contrast Agents Market, by Type, 2021–2030 (USD Million)
Table 99 Middle East & Africa: Microbubbles/Ultrasound Contrast Agents Market, by Application, 2021–2030 (USD Million)
Table 100 Middle East & Africa: Microbubbles Contrast Agents Market for Diagnostic Imaging Applications, by Type, 2021–2030 (USD Million)
Table 101 Middle East & Africa: Microbubbles/Ultrasound Contrast Agents Market, by End User, 2021–2030 (USD Million)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Estimation
Figure 7 Global Microbubbles/Ultrasound Contrast Agents Market, by Type, 2023 VS. 2030 (USD Million)
Figure 8 Global Microbubbles/Ultrasound Contrast Agents Market, by Application, 2023 VS. 2030 (USD Million)
Figure 9 Global Microbubbles/Ultrasound Contrast Agents Market, by End User, 2023 VS. 2030 (USD Million)
Figure 10 Global Microbubbles/Ultrasound Contrast Agents Market, by Geography
Figure 11 Market Dynamics
Figure 12 Global Microbubbles/Ultrasound Contrast Agents Market, by Type, 2023 VS. 2030 (USD Million)
Figure 13 Global Microbubbles/Ultrasound Contrast Agents Market, by Application, 2023 VS. 2030 (USD Million)
Figure 14 Global Microbubbles/Ultrasound Contrast Agents Market, by End User, 2023 VS. 2030 (USD Million)
Figure 15 Global Microbubbles/Ultrasound Contrast Agents Market, by Geography, 2023 VS. 2030 (USD Million)
Figure 16 North America: Microbubbles/Ultrasound Contrast Agents Market Snapshot
Figure 17 Europe: Microbubbles/Ultrasound Contrast Agents Market Snapshot
Figure 18 Asia-Pacific: Microbubbles/Ultrasound Contrast Agents Market Snapshot
Figure 19 Latin America: Microbubbles/Ultrasound Contrast Agents Market Snapshot
Figure 20 Global Microbubbles/Ultrasound Contrast Agents Market: Competitive Dashboard
Figure 21 Global Microbubbles/Ultrasound Contrast Agents Market: Competitive Benchmarking Based on Product
Figure 22 Global Microbubbles/Ultrasound Contrast Agents Market: Market Share Analysis, (2022)
Figure 23 Lantheus Holdings, Inc.: Financial Overview (2022)
Figure 24 GE HealthCare Technologies Inc.: Financial Overview (2022)
Figure 25 Bristol-Myers Squibb Company: Financial Overview (2022)
Figure 26 Daiichi Sankyo Company, Limited: Financial Overview (2022)
Figure 27 Siemens Healthineers AG: Financial Overview (2022)
Figure 28 Bayer AG: Financial Overview (2022)
Figure 29 Fujifilm Holdings Corporation: Financial Overview (2022)
Author Name:
Proudly Partnering With Enterprises Around the Globe
Quick Contact
Related Reports
Contact Lens Market - Global Opportunity Analysis And Industry Forecast (2024-2031)
Published Date: Oct-2024
Veterinary Ultrasound Market - Global Opportunity Analysis and Industry Forecast (2024-2030)
Published Date: Jun-2024
Ultrasound Transducers Market - Global Opportunity Analysis And Industry Forecast (2024-2030)
Published Date: Jun-2024
Portable Ultrasound Market - Global Opportunity Analysis and Industry Forecast (2024-2031)
Published Date: Mar-2024
